| Fymskina 130 mg Concentrate for solution for infusion EU/1/24/1862/003 |
Ustekinumab |
Formycon AG |
— |
| Fymskina 45 mg Solution for injection EU/1/24/1862/001 |
Ustekinumab |
Formycon AG |
— |
| Fymskina 90 mg Solution for injection EU/1/24/1862/002 |
Ustekinumab |
Formycon AG |
— |
| Imuldosa 130 mg Concentrate for solution for infusion EU/1/24/1872/003 |
Ustekinumab |
Accord Healthcare S.L.U. |
— |
| Imuldosa 45 mg Solution for injection EU/1/24/1872/001 |
Ustekinumab |
Accord Healthcare S.L.U. |
— |
| Imuldosa 90 mg Solution for injection EU/1/24/1872/002 |
Ustekinumab |
Accord Healthcare S.L.U. |
— |
| Otulfi 130 mg Concentrate for solution for infusion EU/1/24/1863/003 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Otulfi 45 mg Solution for injection EU/1/24/1863/001 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Otulfi 45 mg Solution for injection pre-filled pen EU/1/24/1863/005 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Otulfi 90 mg Solution for injection EU/1/24/1863/002 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Otulfi 90 mg Solution for injection in Pre-filled pen EU/1/24/1863/006 |
Ustekinumab |
Fresenius Kabi Deutschland GmbH |
— |
| Pyzchiva 130 mg concentrate for solution for infusion EU/1/24/1801/003 |
Ustekinumab |
Samsung Bioepis NL B.V. |
— |
| Pyzchiva 45 mg solution for injection in pre-filled pen EU/1/24/1801/004 |
Ustekinumab |
Samsung Bioepis NL B.V. |
— |
| Pyzchiva 45 mg solution for injection in pre-filled syringe EU/1/24/1801/001 |
Ustekinumab |
Samsung Bioepis NL B.V. |
— |
| Pyzchiva 90 mg solution for injection in pre-filled pen EU/1/24/1801/005 |
Ustekinumab |
Samsung Bioepis NL B.V. |
— |
| Pyzchiva 90 mg solution for injection in pre-filled syringe EU/1/24/1801/002 |
Ustekinumab |
Samsung Bioepis NL B.V. |
— |
| Qoyvolma 130 mg concentrate for solution for infusion EU/1/25/1925/003 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| Qoyvolma 45 mg solution for injection in pre-filled syringe EU/1/25/1925/001 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| Qoyvolma 90 mg solution for injection in pre-filled syringe EU/1/25/1925/002 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| STELARA 130 mg Concentrate for solution for infusion EU/1/08/494/005 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 45 mg Solution for injection EU/1/08/494/003 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 45 mg Solution for injection EU/1/08/494/001 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 90 mg Solution for injection EU/1/08/494/004 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STEQEYMA 130 mg Concentrate for solution for infusion EU/1/24/1844/003 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| STEQEYMA 45 mg Solution for injection EU/1/24/1844/001 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| STEQEYMA 90 mg Solution for injection EU/1/24/1844/002 |
Ustekinumab |
Celltrion Healthcare Hungary Kft. |
— |
| Usgena 130 mg concentrate for solution for infusion EU/1/25/1987/005 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Usgena 45 mg solution for injection EU/1/25/1987/001 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Usgena 45 mg solution for injection in pre-filled syringe EU/1/25/1987/002 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Usgena 90 mg solution for injection in pre-filled syringe EU/1/25/1987/003-004 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Usrenty 130 mg concentrate for solution for infusion EU/1/25/1973/004 |
Ustekinumab |
Biocon Biologics Ireland Limited |
— |
| Usrenty 45 mg solution for injection EU/1/25/1973/001 |
Ustekinumab |
Biocon Biologics Ireland Limited |
— |
| Usrenty 45 mg solution for injection in pre-filled syringe EU/1/25/1973/002 |
Ustekinumab |
Biocon Biologics Ireland Limited |
— |
| Usrenty 90 mg solution for injection in pre-filled syringe EU/1/25/1973/003 |
Ustekinumab |
Biocon Biologics Ireland Limited |
— |
| Usymro 130 mg concentrate for solution for infusion EU/1/25/1957/004 |
Ustekinumab |
Gedeon Richter Plc |
— |
| Usymro 45 mg solution for injection EU/1/25/1957/001 |
Ustekinumab |
Gedeon Richter Plc |
— |
| Usymro 45 mg solution for injection in pre-filled syringe EU/1/25/1957/002 |
Ustekinumab |
Gedeon Richter Plc |
— |
| Usymro 90 mg solution for injection in pre-filled syringe EU/1/25/1957/003 |
Ustekinumab |
Gedeon Richter Plc |
— |
| Uzpruvo 130 mg concentrate for solution for infusion EU/1/23/1784/005 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Uzpruvo 45 mg solution for injection in pre-filled syringe EU/1/23/1784/001 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| Uzpruvo 90 mg solution for injection in pre-filled syringe EU/1/23/1784/004 |
Ustekinumab |
Stada Arzneimittel AG |
— |
| WEZENLA 130 mg Concentrate for solution for infusion EU/1/24/1823/004 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 45 mg Solution for injection EU/1/24/1823/001 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 45 mg Solution for injection pre-filled syringe EU/1/24/1823/002 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 90 mg Solution for injection pre-filled syringe EU/1/24/1823/003 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| Yesintek 130 mg Concentrate for solution for infusion EU/1/24/1892/004 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 45 mg Solution for injection EU/1/24/1892/002 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 45 mg Solution for injection Subcutaneous use EU/1/24/1892/001 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 90 mg Solution for injection EU/1/24/1892/003 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |